In conclusion, the overactivation of PRMT1 in endothelial cells primarily results in a decrease in NO, increased oxidative stress, and exacerbated inflammation through both ADMA‐dependent and independent mechanisms, thus forming the pathological foundation of endothelial dysfunction. The gene discussed is PRMT1; the disease is endothelial dysfunction.